Cymabay Therapeutics Inc (NASDAQ:CBAY)

3.93
Delayed Data
As of Dec 01
 +0.56 / +16.62%
Today’s Change
1.67
Today|||52-Week Range
4.30
+16.27%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Cymabay Therapeutics Inc have a median target of 10.00, with a high estimate of 14.00 and a low estimate of 8.00. The median estimate represents a +154.45% increase from the last price of 3.93.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Cymabay Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.26
Sales
$6.0M
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.56%
 
 
 
 
 
 
Growthannually 6.12%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.